Recent studies have revealed that TFEB nuclear translocation was promoted by pharmacologically activating the AMPK pathway and eventually alleviated hepatic steatosis in HFD-fed mice (Chen et al., 2019). The gene discussed is TFEB; the disease is fatty liver disease.